Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
Magotra A, Sharma A, Gupta AP, Wazir P, Sharma S, Singh PP, Tikoo MK, Vishwakarma RA, Singh G, Nandi U. Magotra A, et al. Among authors: singh pp, singh g. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Aug 15;1060:200-206. doi: 10.1016/j.jchromb.2017.06.015. Epub 2017 Jun 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28623772
Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
Magotra A, Sharma A, Singh S, Ojha PK, Kumar S, Bokolia N, Wazir P, Sharma S, Khan IA, Singh PP, Vishwakarma RA, Singh G, Nandi U. Magotra A, et al. Among authors: singh pp, singh g, singh s. Pulm Pharmacol Ther. 2018 Feb;48:151-160. doi: 10.1016/j.pupt.2017.11.006. Epub 2017 Nov 21. Pulm Pharmacol Ther. 2018. PMID: 29174840
Synthesis of new generation triazolyl- and isoxazolyl-containing 6-nitro-2,3-dihydroimidazooxazoles as anti-TB agents: in vitro, structure-activity relationship, pharmacokinetics and in vivo evaluation.
Munagala G, Yempalla KR, Singh S, Sharma S, Kalia NP, Rajput VS, Kumar S, Sawant SD, Khan IA, Vishwakarma RA, Singh PP. Munagala G, et al. Among authors: singh pp, singh s. Org Biomol Chem. 2015 Mar 28;13(12):3610-24. doi: 10.1039/c5ob00054h. Org Biomol Chem. 2015. PMID: 25670502
Development and validation of a highly sensitive LC-MS/MS-ESI method for quantification of IIIM-019-A novel nitroimidazole derivative with promising action against Tuberculosis: Application to drug development.
Kour G, Chandan BK, Khullar M, Munagala G, Singh PP, Bhagat A, Gupta AP, Vishwakarma RA, Ahmed Z. Kour G, et al. Among authors: singh pp. J Pharm Biomed Anal. 2016 May 30;124:26-33. doi: 10.1016/j.jpba.2016.02.027. Epub 2016 Feb 22. J Pharm Biomed Anal. 2016. PMID: 26922579
686 results